Strengthening Evidence Generation to Support Pricing & Reimbursement

• Clarifying the data elements and evidence needed to assess durability, effectiveness, and long-term value to payers
• Evaluating how study design and population considerations influence evidence strength and reimbursement decisions
• Identifying approaches for generating credible clinical and economic evidence to support market access

Speakers:

Eugean Jiwanmall

Lead Research Analyst for Medical Policy & Health Technology Evaluation

Independence Blue Cross Family of Companies & Independence Health Group